SYNERGIZED INNOVATION & SUSTAINED EVOLUTION THE 2nd ASIA MEDICAL WEEK ASIAN MEDICAL INNOVATION & DEVELOPMENT FORUM 2019 Fudan Zhongshan International Oncology Summit & Annual Conference of Fudan Zhongshan Cancer Center

Shanghai / Shenzhen Oct.19-21 2019

ACTIVITIES RECAP 2018

South Korea 2019

Statistics 11 4 4 1000+ 30 81% Sub-Forums Private Sessions Clinial Exchange Visit Attendees Countries & Regions Top Management Presidents, Vice-Presidents, CEOs, Directors or Officers from Governments, MOHs & Hospitals.

Overseas Visitors

Armenia Australia Bangladesh Belarus Brazil China Egypt France Greece India

Indonesia Italy Japan Kazakhstan Kenya Malaysia Myanmar Northern Cyprus Pakistan Philippines

Russia Singapore South Korea Sri Lanka Thailand Turkey Ukraine UK US Vietnam Launching Ceremony

Dear Professors,

We take a great pleasure in inviting you to the 2019 Asian Medical Week, which is held in from October 19th to October 21st , 2019. Asia Medical Week is a prominent academic event for promoting medical communication and cooperation in the Asia-Pacific region. With the theme focusing on "Medical Innovation & Development", 2019 Asia Medical Week is dedicated to providing an effective communication platform for international healthcare community and industry to showcase China’s latest oncology, promote sharing for high-quality healthcare resources and advocate high-tech cooperation for modern medicine.

Towards a vision of "Collaborative Innovation, Sustainable Progress", and Fudan University Zhong Shan Hospital Cancer Center (FUZSCC) will host the 2019 Asian Medical Week - - Medical Innovation & Development Forum, featuring 2019 Fudan Zhongshan International Oncology Summit, in concurrent with the annual meeting of FUZSCC. To pace the internationalization and development of China healthcare system through in-depth communication and collaboration between Asia-Pacific countries, the program will focus on the newest advances in tumor management and establish “the Belt and Road” Oncology Alliance during the event. At that FAN Jia time, there will be thousands of clinical, diagnostic and nursing experts Executive Chairman of the Forum at home and abroad to discuss the overall management and the latest Academician of Chinese Academy of Sciences diagnosis and treatment progress of cancer prevention and treatment, President of Shanghai Zhongshan Hospital, Fudan University seeking a common future development of the medical community.

In view of your outstanding achievement and influence in medical field, we hope that you can provide insights for the improvement of cancer prevention and give advice on the development of the discipline.

We can expect the sweet-scented osmanthus blooming everywhere this autumn. We sincerely look forward to your cooperation for this grand event in Shanghai!

Sincerely,

02 Host

WANG Xin Secretary General, Committee of the CPC, Zhongshan Hospital, Fudan University

China

Opening Address Opening Address

ZENG Yixin ZONG Ming Deputy Director, Deputy Mayor, National Health Commission, P.R.C. Shanghai Municipal Government

China China

Opening Address Opening Address

FAN Jia Ivan STILIDI Director, Director, Zhongshan Hospital, Fudan University National Medical Research Center of Oncology named after N.N. Blokin, China Russian Federation

Opening Address Opening Address

JIAO Yang LI Zaiwen Director, Senior Vice President, Zhongshan Hospital, Fudan University Shenzhen Mindray BioMedical Electronics Co., Ltd. China China

Fan Jia, Chinese Sciences Academician, Director of Zhongshan Hospital, Fudan University, pointed that--

“Asia Medical Week” has become a very important academic platform for medical exchange & collaboration in Asia-Pacific & the world. Experts and scholars from world-renowned hospitals had discussed in-depth on topics of cutting-edge technology, hospital construction, quality management, performance system & doctor-patient relationship with the theme focusing on “Medical Innovation & Development” in 2018. And this year, towards a vision of "Collaborative Innovation, Sustainable Progress", Fudan University Zhong Shan Hospital Cancer Center (FUZSCC) hosted the 2nd Asia Medical Week to execute “the Belt & Road” Initiative & “Healthy China” Initiative. Sub Forums VENUE VENUE VENUE VENUE VENUE VENUE

Host A B C D E F ZHU Chouwen Vice President of Zhongshan Hospital, Fudan University

China

New Practice of Precise Tumor Advances in Cancer Radiotherapy Immunotherapy: from Melanoma to other Types LU Jiade Executive Vice President of Shanghai Proton Michele MAIO & Heavy Ion Center (SPHIC) Director, Tumor Immunization Center, Professor of Clinical Oncology of Fudan Siena University University School of Medicine Director of Oncology, Siena University

Italy VENUE VENUE Master’s Forum Master’s Forum A2 A2

Molecular Typing of Liver New Approaches in Treatment Cancer of Hepatobiliary System Oncopathology Dhanpat JAIN Petrovsky VALERYEVICH Director, Section of Gastrointestinal & Liver Fellowship Program, Yale University Executive Director of Association of School of Medicine Oncologists of Russia Member of the American Society for USA Brachytherapy Russia Fedevation VENUE VENUE Zhongshan International Forum Zhongshan International Forum A3 on Digestive Tumors A3 on Digestive Tumors

Current Status of Systemic Perioperative Treatment Therapy for Unresectable Strategy for Esophageal Cancer Colorectal Cancer in Japan TAN Lijie Kentaro YAMAZAKI Director of Thoracic/Esophageal Surgery Clinical Trial Coordination Unit Division of Dept. y Gastrointestinal Oncology Zhongshan Hospital, Fudan University Shizuoka Cancer Center China Japan VENUE VENUE Zhongshan International Forum Zhongshan International Forum A3 on Digestive Tumors A3 on Digestive Tumors VENUE VENUE VENUE VENUE VENUE VENUE

Host A B C D E F LIU Tianshu Director of Oncology Department, Zhongshan Hospital, Fudan University

China

Minimally Invasive Surgical Progress of WHO & AJCC on Treatment of Early Thymoma Neuroendocrine Neoplasms

Takashi SUDA Grace KIM Fujita Health University School of Medicine Vice Chair of Clinical Services Department of Pathology, Medical Director of Pathology Japan Services, University of Califonia San Francisco

USA VENUE VENUE Forum on Forum on Hepatobiliary & Pancreatic Tumor C2 Mediastinal Tumor C3 and Immune Pathology

AI & Tumor Immunotherapy The Surgery for Ovarian Cancer Patients with High Tumor Burden YEONG Poh Sheng Joe Group Leader, Institute of Molecular & ZHU Jianqing Cell Biology Chief Physician, Director of Gynecology & Research Pathologist, Anatomical Oncology Dept., Pathology Department, SGH Cancer Hospital of Chinese Academy of Singapore Science Zhejiang Cancer Hospital China VENUE VENUE Forum on Hepatobiliary & Forum on C3 Pancreatic Tumor and Immune Pathology D Gynecological Oncology

Update & Controversy in Lobular Treatment of Cancer Pain Carcinoma in Situ of the Breast XU Bei Yunn-Yi CHEN Associate Chief Physician Oncology Department, Zhongshan Hospital, Professor, University of California San Fudan University Francisco (UCSF) Clinical Pathology, Step 4 Pathology School China of Medicine

USA VENUE VENUE Forum on Forum on E Breast Tumor F2 Tumor Palliative and Nursing Private Sessions VENUE

Host G HUANG Pengcheng Vice President of Domestic Sales & Marketing Department of Mindray Group

China

Opening Address Opening Address

YANG Yong Jean-Marc DURRHEIME Marketing Director, Director of Biomedical International UIS Sales & Marketing Engineering Dept. Department of Mindray Group Centre Hospitalier de Haguenau

China France VENUE VENUE Session on Session on G1 Ultrasound Application G1 Ultrasound Application

Opening Address Opening Address

Richard BARR Alexis KELEKIS Professor of Radiology at Ohio professor of diagnostic and Medical University interventional musculoskeletal radiology at the University of Athens USA Greec VENUE VENUE Session on Session on G1 Ultrasound Application G1 Ultrasound Application

Opening Address Opening Address

HUANG Pintong WANG Wenping Chief Physician Director of Ultrasound Director of the Department of Ultrasound, Medicine Department the Second Zhongshan Hospital, Fudan University Affiliated Hospital Zhejiang University School of Medicine China

China VENUE VENUE Session on Session on G1 Ultrasound Application G1 Ultrasound Application VENUE

Host G LI Weiping President of Renji Hospital, Shanghai Jiaotong University

China

Opening Address Opening Address

YIN Luntao Alex Enriquez Vice President of Mindray Group ALEGRADO

China President of ARC Oncology Group, Inc., Philippines VENUE VENUE Session on Session on G2 Comprehensive Topics G2 Comprehensive Topics

The Impact of International Current Status, History and Cooperation in Child Liver Characteristics of Dialysis Transplantation Therapy in Japan

Azura Binti MANSOR Tetsuya Yamada Deputy Director of Clinical Services (Surgical), Executive Managing Director, Kaikoukai University Malaya Medical Centre Healthcare Corporation

Malaysia Japan VENUE VENUE Session on Session on G2 Comprehensive Topics G2 Comprehensive Topics

Challenges in Delivery of Quality Healthcare Service & International Care in East Africa & Expanding Cooperation in South Asia Access to Healthcare through Efficiency Improvement & Cost Farooq Jamil Reduction Special Secratary Health, Khyber Pakhtunkhwa Province, MOH

Shawn Bolouki Pakistan CEO, Agakhan University Hospital,

Kenya VENUE VENUE Session on Session on G2 Comprehensive Topics G2 Comprehensive Topics Clinical Exchange Visit VENUE VENUE H1 H2

Zhongshan Hosptial Renji Hosptial Zhongshan Hospital, Fudan University, is a public institution under the Renjin is the first western hospital in Shanghai and the second in China. William supervision of the National Health Commission. It is a general and teaching- Lockhart, a missionary from Britain, rented a house in the inhabited area near Da oriented hospital attached to Fudan University. The hospital opened in 1937 and Dong Men (Big East Gate) of Shanghai County and opened the hospital in 1844, is one of the earliest large-scale general hospitals established and managed by the 24th year of the Qing dynasty Daoguang Emperor.In 1985, Shanghai Second Chinese health professionals. Zhongshan Hospital currently covers an area of Medical College renamed as Shanghai Second Medical University (SSMU), and 96000 square meters, the total floor area of 358000 square meters, with approved Renji Hospital became an affiliated hospital of SSMU. At the end of 1990, Renji had 2005 beds. 607 beds and 1,211 staff members. In 2005, Shanghai Second Medical University was merged to Shanghai Jiao Tong University and Renji Hospital then became an affiliated hospital of Shanghai Jiao Tong University School of Medicine. VENUE VENUE H3 H4

Ruijin Hosptial Huashan Hosptial Ruijin Hospital was founded in 1907, formerly known as Sainte Marie Hospital in was founded in 1907 as the Chinese Red Cross General Hospital. English and Guangci Hospital in Chinese. It has a land area of 120,000 sq. meters, From 1913 to 1918, it served as a of Harvard University, and among which, buildings cover 245,000 sq. meters and green field, 40,000 sq. regularly sent its doctors and researchers to Harvard for training. It has been a meters. Ruijin Hospital has some of the city's most respected and accomplished teaching hospital of the National Central University Medical College since 1928. It local doctors and a number of world-recognized medical scientists and experts, was renamed as Huashan Hospital in 1956. In 2004, Huashan re-established sister Ruijin Hospital has a comprehensive range of medicine, with 34 clinical hospital relationship with Massachusetts General Hospital, the main teaching departments, seven departments of medical technology and nine institutes. hospital of Harvard.The main branch of Huashan Hospital has 1,216 beds. In 2014, it treated 60,000 inpatients and 3.84 million outpatients, half of whom came from outside of Shanghai. More than 40,000 surgeries were performed in the same year.

Founded in 1991, Mindray is one of the leading global providers of medical devices and solutions. Firmly committed to ourmission to "advance medical technologies to make healthcare more accessible", we are dedicated to innovation in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging System. Today, Mindray' s products and services are serving healthcare facilities in over 190 countries and regions. FUDAN UNIVERSITY ZHONGSHAN HOSPITAL THE “BELT & ROAD” CANCER PREVENTION & TREATMENT ALLIANCE MEMORANDUM OF UNDERSTANDING

In order to promote the common development of health undertakings in regions and strengthen bilateral medical innovation and cooperation, the parties jointly attended the "2nd Asia Medical Week" on October 19, 2019 in Shanghai, China. The meeting will be initiated by Fudan University Zhong Shan Cancer Center (FUZSCC) to establish the “Belt and Road” Cancer Prevention Alliance. Exchanges and cooperation in the field of health are an important part of China and the countries along the “Belt and Road”. We will deepen the friendship between the people of Shanghai and the countries along the “Belt and Road” and enrich China and the “Belt and Road”. The connotation of national cooperation and the closer construction of Shanghai and the community of destiny along the “Belt and Road” is really essential at this moment. The members of the Alliance reached the following consensus on the principle of mutual benefit and mutual benefit: 1-Promote the exchange of experiences between Shanghai and the countries along the “Belt and Road” on public health issues such as treatment concepts, prevention and management of malignant tumor diseases, and jointly respond to challenges. 2-Strengthen the interaction of health human resources. According to the consensus of all parties, carry out activities such as the exchange of health and medical experts, the organization of various health professional and technical training courses and seminars, and strengthen the exchange of experience and personnel training. The purpose of cooperation is to benefit all parties, strengthen experience sharing, enhance academic exchanges, promote scientific research cooperation, and further promote friendship and friendly development of the country.

Fudan University Zhong Shan Cancer Center (FUZSCC) Shanghai, China 19 Oct. 2019 Fudan University Zhong Shan Cancer Center

Fudan University Zhong Shan Cancer Center (FUZSCC) was initiated in 2016. Facing the demand and trend for cancer prevention and treatment domestically and globally, it was dedicated to establish a top-level cancer center for prevention and treatment that is guided by clinical application, focusing on quality, to comprehensively strengthen clinic, education, research and prevention capacity in cancer area. Up to 2019, with the increasing volume of cancer patients diagnosed and treated, FUZSCC has been clearly developed and defined its structures and functions. Prof. Jia Fan, the Academician of the Academy of Science China, and the President of Zhong Shan Hospital, led the FUZSCC as the director.

Organizer

Host Hospitals

Golden Sponsor

www.amw2019.com Scan Bar-Code & Get Wonderful Moments!